Overexpression of the α2,6-Sialyltransferase, ST6Gal I, in a Low Metastatic Variant of a Murine Lymphoblastoid Cell Line Is Associated with Appearance of a Unique ST6Gal I mRNA
- 2 November 1999
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 264 (3) , 619-621
- https://doi.org/10.1006/bbrc.1999.1562
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- The gene encoding β-galactoside α2,6-sialyltransferase maps to mouse Chromosome 16Mammalian Genome, 1997
- Murine hepatic β-galactoside α2,6-sialyltransferase gene expression involves usage of a novel upstream exon regionGlycoconjugate Journal, 1997
- Novel Heterogeneity Exists in the 5′-Untranslated Region of the β-Galactoside α2,6-Sialyltransferase mRNAs in the Human B-Lymphoblastoid Cell Line, LouckesBiochemical and Biophysical Research Communications, 1996
- Transcription of the β-galactoside α2,6-sialyltransferase gene in B lymphocytes is directed by a separate and distinct promoter†Glycobiology, 1996
- Sialylation and malignant potential in tumour cell glycosylation mutantsGlycobiology, 1994
- An intracisternal A‐particle sequence codes for an antigen recognized by syngeneic cytolytic T lymphocytes on a mouse spontaneous leukemiaEuropean Journal of Immunology, 1994
- α2, 6 sialylation ofN-acetyllactosaminic sequences in human colorectal cancer cell lines. Relationship with non-adherent growthInternational Journal of Cancer, 1991
- Increased CMP‐NeuAc:Galβ1,4GlcNAc‐R α2,6 sialyltransferase activity in human colorectal cancer tissuesInternational Journal of Cancer, 1989
- Asn-linked oligosaccharides in lectin-resistant tumor-cell mutants with varying metastatic potentialEuropean Journal of Biochemistry, 1986
- CO‐reversion of a lectin‐resistant mutation and non‐metastatic phenotype in murine tumor cellsInternational Journal of Cancer, 1986